Movac

Latest fund size

$107M

Announced

June 30, 2026

Global HQ

New Zealand

Members only

Check size

$3M–$17M

Members only

Stage focus

Series A, Series B, Growth

Members only

Regions of investment

New Zealand, Australia

Members only

About

Movac is Auckland and Wellington-based venture and growth capital firm founded in 1998, New Zealand's most experienced and longest-running venture capital firm, with nearly three decades of backing Kiwi technology companies. The firm has backed more than 60 companies across its fund history, consistently delivering top-quartile and top-decile returns to investors based on cash returned. Movac Growth Fund 7 is the firm's seventh growth-stage vehicle and its largest to date.

Contact info

movac.com‍

+64 27 246 4936

‍

Mark Vivian — Partner

mark.vivian@movac.co.nz

‍

Phil McCaw — Partner

phil@movac.co.nz

‍

Mark Stuart — Partner

‍

Fi Foster — Partner

fiona@movac.co.nz

‍

‍

Members only

Names, roles, emails and LinkedIn profiles for the team, plus the fund's website.

Investment focus

Movac's growth funds back high-growth New Zealand technology companies across enterprise SaaS, fintech, legaltech, agtech, aerospace, and AI-enabled software at Series A, B, and C+.

The firm targets companies with proven unit economics, disciplined use of capital, and the ability to scale revenues past $100 million annually. Up to 30% of each growth fund may be deployed offshore, typically in companies with strong New Zealand connections.

Members only

What the fund looks for in founders and which sectors it backs.

Fund

Movac Growth Fund 7 (MGF7) completed a first close of $107M (NZ$185M) in June 2026, almost double its initial target, achieved within six months of launch.

The fund is targeting a hard cap of $116M (NZ$200M).

LPs include NZ Super Fund (cornerstone, backing Movac growth funds for over a decade), Government Superannuation Fund Authority, Forsyth Barr, and Ngāi Tahu Holdings, alongside approximately $46M (NZ$80M) from Active Investor Plus (AIP) visa investors across the last two Movac funds.

MGF7 is an approved Acceptable Managed Fund under New Zealand's AIP visa program. Initial checks range from $3–17M (NZ$5–30M+), with follow-on capital reserved for future rounds.

Members only

Fund size, LPs and track record.

Other information

Leadership

Mark Vivian is Partner and the fund's primary external spokesperson for MGF7.

Phil McCaw is Partner and one of the founding architects of Movac's growth strategy.

Mark Stuart is Partner.

Jason Graham is Partner.

David Beard is Partner.

Fi Foster is Partner, recently promoted in March 2026.

‍

Investment Strategy

Movac writes initial checks of $3–17M (NZ$5–30M+) at Series A through C+, targeting a concentrated portfolio of companies with demonstrated product-market fit, disciplined capital use, and a clear path to $100M+ ARR.

The firm takes active board-level involvement and supports portfolio companies on go-to-market execution, international expansion, and subsequent fundraising.

The AIP visa program integration is a structural feature of MGF7, enabling investor migrants to co-invest alongside institutional LPs and access Movac's network.

‍

Notable Investments

  • Auror
  • ReLeased
  • LawVu
  • Crimson Education
  • Dawn Aerospace
  • TracPlus
  • Alimetry
  • Wellumio
  • AutoGrab
  • Trade Me
  • Vend
  • Unleashed Software
  • Aroa Biosurgery
  • PowerbyProxi
  • Tradify

‍

Notable Exits

  • Trade Me (NZX IPO; acquired by Apax Partners)
  • Vend (acquired by Lightspeed for ~$490M)
  • Unleashed Software (acquired by The Access Group)
  • PowerbyProxi (acquired by Apple)
  • Aroa Biosurgery (NZX IPO)

‍

‍

Members only

Leadership, investment strategy, notable investments and exits.

Unlock this fund's full profile

✓ Emails and LinkedIn for the team

✓ Check size, stage focus and regions of investment

✓ LPs, notable investments and exits

✓ Search and filters across 700+ funds

Unlock this fund and 700+ more

From $14/month, billed yearly. Cancel any time.

Read the newsletter that top VCs and founders keep in their inbox.

Join the weekly newsletter